Rocket Lab (RKLB) began Monday’s trading session at $107.24, marking an 8.33% decline. The downturn followed the company’s official entry into the Nasdaq-100 Index, which prompted a textbook “sell-the-news” response from traders.
Rocket Lab USA, Inc., RKLB
Shares had experienced a significant run-up ahead of the index inclusion as investors positioned themselves for the announcement. However, once the milestone became reality, profit-taking ensued — a familiar market dynamic when long-anticipated events finally materialize.
The decline was further exacerbated by sector-wide selling in space-related equities. The recent SpaceX initial public offering seems to have redirected investor focus and capital away from smaller aerospace companies, creating additional headwinds throughout the industry.
Despite the share price retreat, operational momentum continues. Rocket Lab is actively preparing the payload for its 90th Electron mission, a significant achievement that demonstrates the maturity of its launch operations.
From a financial perspective, the first quarter delivered strong results. Revenue totaled $200.35 million, representing a 63.4% year-over-year increase and surpassing the $189.65 million analyst estimate. Earnings per share came in at -$0.07, aligned with expectations and showing improvement from the -$0.12 loss recorded in the prior-year quarter.
The company continues to operate at a deficit, posting a net margin of -26.87% and a negative return on equity of 11.72%. Wall Street forecasts full-year EPS of -$0.29.
Not all market participants are reducing exposure. HSBC Holdings substantially expanded its RKLB stake by 613.9% during the fourth quarter, acquiring an additional 1.35 million shares. The firm’s total position now comprises 1.57 million shares, worth approximately $110.7 million based on the SEC filing date.
Several other institutional players also increased their allocations. Sara Bay Financial, ORG Partners, Traynor Capital, Capital Advisors Wealth Management, and Quadcap Wealth Management all expanded their RKLB holdings in Q4. Institutional investors collectively control 71.78% of outstanding shares.
Wall Street currently assigns the stock a Moderate Buy consensus rating with an average price target of $102.76 — slightly below Monday’s opening price, providing perspective on the recent sell-off.
While institutional buyers were adding positions in Q4, company insiders have been reducing their stakes in 2025. During the past 90 days, insiders sold a combined 573,515 shares worth $76.4 million.
Insider Frank Klein disposed of 36,860 shares on May 28 at an average price of $147.42, generating proceeds of $5.43 million. Insider Marvin Bradford Clevenger sold 3,500 shares on the same date at $146.67. Both transactions were conducted through predetermined Rule 10b5-1 trading arrangements.
RKLB’s 52-week trading range spans from $27.84 to $151.00. The stock’s 50-day moving average sits at $105.58, while the 200-day moving average stands at $83.61. Despite recent weakness, RKLB maintains a year-to-date gain of 53.73%.
The aerospace company commands a market capitalization of $62.07 billion, maintains a debt-to-equity ratio of 0.02, and exhibits a beta of 2.48 — indicating substantial price volatility. RKLB’s current ratio registers at 4.47, with a quick ratio of 4.02.
The post Rocket Lab (RKLB) Stock Plunges 8% Following Nasdaq-100 Entry in Textbook Sell-Off appeared first on Blockonomi.

